MENU
+Compare
ANGO
Stock ticker: NASDAQ
AS OF
Dec 1 closing price
Price
$12.97
Change
+$0.57 (+4.60%)
Capitalization
534.36M

ANGO AngioDynamics Forecast, Technical & Fundamental Analysis

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings... Show more

ANGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ANGO with price predictions
Dec 01, 2025

ANGO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ANGO turned positive on December 01, 2025. Looking at past instances where ANGO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on ANGO as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ANGO moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANGO advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 218 cases where ANGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ANGO moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANGO broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.988) is normal, around the industry mean (9.251). P/E Ratio (0.000) is within average values for comparable stocks, (163.356). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.549). ANGO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.768) is also within normal values, averaging (110.799).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
ANGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ANGO is expected to report earnings to -10 cents per share on January 01

AngioDynamics ANGO Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.14
Q4'24
Beat
by $0.07
The last earnings report on October 02 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 603.25K shares outstanding, the current market capitalization sits at 534.36M.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices used by radiologists, vascular surgeons and other physicians

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Plaza Drive
Phone
+1 518 795-1400
Employees
815
Web
https://www.angiodynamics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOIGX13.15N/A
N/A
Northern International Equity
NCGFX73.41N/A
N/A
New Covenant Growth
PMDHX20.06N/A
N/A
Principal Small-MidCap Dividend Inc R6
ACILX31.64N/A
N/A
American Century Heritage G
CAISX11.06-0.17
-1.51%
Calamos International Small Cap Gr A

ANGO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+4.60%
STRRP - ANGO
48%
Loosely correlated
+1.92%
XRAY - ANGO
37%
Loosely correlated
-1.32%
BLFS - ANGO
37%
Loosely correlated
-4.23%
MXCT - ANGO
36%
Loosely correlated
-7.67%
RGEN - ANGO
32%
Poorly correlated
-2.73%
More

Groups containing ANGO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
+4.60%
Pharmaceuticals: Other
industry (103 stocks)
28%
Poorly correlated
-0.87%
Pharmaceuticals
industry (377 stocks)
25%
Poorly correlated
-0.56%